LOS ANGELES, CA, United States, via eTeligis Inc., 05/20/2014 - - SK3 Group, Inc.'s (OTC Pink: SKTO) (PINKSHEETS: SKTO) (the "Company") is pleased to announce that it will release the audio on a conference call by its principals which will be posted on the Company's website, www.medicalgreens.com by June 1, 2014. Investors and existing shareholders are encouraged to e-mail the Company's investor relations account with questions regarding the Company and its operations before May 22, 2014. The Company intends to incorporate many of the investor and shareholder questions it receives in this and future conference calls.
FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.
About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT:
SK3 Group, Inc.
Investor Relations
investors@medicalgreens.com
SOURCE: SK3 Group, Inc.